Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Bicalutamide may help treat female pattern hair loss.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Spironolactone effectively treats female pattern hair loss with few side effects.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Lithium can cause sexual issues, hair loss, and skin problems, with some treatments available but needing more research.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A patient had both chronic lupus and systemic scleroderma, requiring careful treatment to manage symptoms.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

No treatment showed clear superiority for lichen planopilaris.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Various medications and vaccines can cause serious side effects.